Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API

Atrial Fibrillation Management and Outcomes

75 та иш

  1. Early Diagnosis of Pulmonary Embolism Related to Clinical Presentation and Vital Signs in the Emergency Department at King Saud Medical City

    Noman Khan, Ahad F Alharbi, Ahmed Q Alshehri +12

    МақолаVenous Thromboembolism Diagnosis and ManagementCureus20220 иқтибос
    ABI

  2. POS-246 EVALUATION OF THE USE OF RIVAROXABAN IN PATIENTS WITH STAGE 4 CKD IN AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesKidney International Reports20220 иқтибос
    ABI

  3. POS-320 EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH OBESITY, TYPE TWO DIABETES AND CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    МақолаAtrial Fibrillation Management and OutcomesKidney International Reports20220 иқтибос
    ABI

  4. MO638: Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Obesity, Type Two Diabetes, CKD

    Sherzod Abdullaev, Ranokhon Igamberdieva

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 иқтибос
    ABI

  5. MO153: Study of the Relationship between Atrial Fibrillation and The Functional State of the Kidneys in Patients with CHF

    Guzal Karimdjanova

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 иқтибос
    ABI

  6. MO162: Renal Function During Long-Term Use of Oral Anticoagulants in Patients with Atrial Fibrillation

    Sherzod Abdullaev, Ranokhon Igamberdieva

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 иқтибос
    ABI

  7. MO143: Dynamics of Renal Function during Anticoagulant Therapy in Stage 4 CKD and AF

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20220 иқтибос
    ABI

  8. Short-term outcomes of catheter ablation in atrial fibrillation in patients with metabolic syndrome

    Jamol Uzokov, BA Alyavi, DD Payziev +2

    МақолаAtrial Fibrillation Management and OutcomesEP Europace20220 иқтибос
    ABI

  9. Oral anticoagulation in end-stage CKD and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesInternational Journal of Health Sciences20220 иқтибос
    ABI

  10. Radiomic Phenotype of Periatrial Adipose Tissue in the Prognosis of Late Postablation Recurrence of Idiopathic Atrial Fibrillation

    J.N. Ilyushenkova, S.I. Sazonova, E.V. Popov +3

    МақолаCardiovascular Disease and AdipositySovremennye tehnologii v medicine20230 иқтибос
    ABI

  11. #3896 SAFETY OUTCOMES OF ORAL ANTICOAGULANT THERAPY IN PATIENTS WITH ATRIAL FIBRILLATION AND CHRONIC KIDNEY DISEASE

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20230 иқтибос
    ABI

  12. Comparative Effectiveness of Aksaritmin and Propafenone in the Prevention of Atrial Fibrillation

    Husniddin Kuchkarov, Н. У. Закиров, R. D. Kurbanov

    МақолаAtrial Fibrillation Management and OutcomesInternational Journal of Biomedicine20230 иқтибос
    ABI

  13. #2964 THE ROLE OF RENAL DYSFUNCTION DURING ANTICOAGULANT USE IN COPD PATIENTS WITH ATRIAL FIBRILLATION

    Guzal Karimdjanova

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20230 иқтибос
    ABI

  14. The results of the use of thrombolytic therapy in acute myocardial infarction at the prehospital and hospital stage

    R Iu Kattakhanova, O. Umirzakov

    МақолаAcute Myocardial Infarction ResearchBIO Web of Conferences20230 иқтибос
    ABI

  15. The case of the peculiarities of electrophysiological examination (EFI) and radiofrequency ablation (RFA) in the atypical form of atrioventricular nodular reciprocal tachycardia (ANRT).

    Khamidov Ilkhom Nasimovich, Saidov Maksud Arifovich, Tursunkulov Ilkhom Kamalovich +3

    МақолаCardiac Arrhythmias and TreatmentsTexas Journal of Medical Science20230 иқтибос
    ABI

  16. ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AND ATRIAL FIBRILLATION

    Asror Olimkulovich Lakhanov, Tashkenbaeva Eleonora Negmatovna, Nasyrova Zarina Akbarovna

    МақолаAtrial Fibrillation Management and OutcomesThe American Journal of Medical Sciences and Pharmaceutical Research20230 иқтибос
    ABI

  17. CLINICAL PROTOCOLS OF DENTAL TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES (REVIEW OF SCIENTIFIC RESEARCH)

    Muratova Saodat Kadirovna, Shukurova Nodira Tillaevna, Teshaev Shokhzhakhon Otabekovich

    МақолаAtrial Fibrillation Management and OutcomesEuropean International Journal of Multidisciplinary Research and Management Studies20240 иқтибос
    ABI

  18. #409 Correlation between ha factor concentration and urinary syndrome in patients with chronic glomerulonephritis when using rivaroxaban

    Asalya Abduvakhitova

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20240 иқтибос
    ABI

  19. #1146 Role of renal dysfunction in the use of anticoagulants in COPD patients with atrial fibrillation

    Guzal Karimdjanova, Dano Egamberdieva, Iroda Ruzmetova

    МақолаChronic Obstructive Pulmonary Disease (COPD) ResearchNephrology Dialysis Transplantation20240 иқтибос
    ABI

  20. #1986 Incidence of renal anemia among patients with atrial fibrillation and chronic kidney disease stage IIIb-V

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20240 иқтибос
    ABI

  21. #1994 Analysis of dynamics of parameters of safety and effectiveness of rivaroxaban in patients with stage IV chronic kidney disease and atrial fibrillation

    Ranokhon Igamberdieva, Sherzod Abdullaev

    МақолаAtrial Fibrillation Management and OutcomesNephrology Dialysis Transplantation20240 иқтибос
    ABI

  22. Comparative Analysis of The Effectiveness of Antihypertensive Therapy Including Spironolactone and Eplerenone in Patients With Essential Hypertension and Atrial Fibrillation

    Г. Ж. Абдуллаева, Г М Раджабова, Nigora Sherbadalova +5

    МақолаHormonal Regulation and HypertensionKardiologiia20240 иқтибос
    ABI

  23. STUDY OF HEMOSTASIS FEATURES IN YOUNG PATIENTS WITH MYOCARDIAL INFARCTION

    U. K. Kamilova, O.Y. Pulatov, R.A. Khusanov

    МақолаVenous Thromboembolism Diagnosis and Management20240 иқтибос
    ABI

  24. First-in-human trial of atrial fibrillation ablation using real-time tissue optical assessment to predict pulsed field lesion durability

    Raphaël P. Martins, Giorgi Papiashvili, Askar Sabirov +4

    МақолаAtrial Fibrillation Management and OutcomesEP Europace20250 иқтибос
    ABI

  25. The Key Takeaways from the 2024 EHRA/HRS/APHRS/LAHRS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation

    Narendra Kumar

    МақолаAtrial Fibrillation Management and OutcomesPremier Journal of Cardiology20250 иқтибос
    ABI